‘Mission (Im)possible II’ – Improving outcomes in COPD

S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study

Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.94 G. Tse, B. Emmanuel, C. Ariti, M. Bafadhel, A. Papi, V. Carter, J. Zhou, D. Skinner, X. Xu, H. Müllerová, Daniel J. Price

S87 Greater exercise tolerance in COPD during acute intermittent compared to endurance shuttle walking protocols: a proof-of-concept study

Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.93 C. Alexiou, F. Chambers, D. Megaritis, L. Wakenshaw, C. Echevarría, I. Vogiatzis

S89 Withdrawal of inhaled corticosteroids from COPD patients with mild or moderate airflow limitation in primary care: a feasibility randomised trial

Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.95 T. Harries, G. Gilworth, C. Corrigan, P. White, P. Murphy, N. Hart, M. Thomas